Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis

Paired-Comparison Study Evaluating the Efficacy and Safety of E6201 Versus Vehicle for the Treatment of Plaque-Type Psoriasis

NCT00539929 ·Status: COMPLETED ·Phase: PHASE2

A Comparison of 188-0551 Solution Versus Vehicle Solution in Subjects With Plaque Psoriasis (Study 203)

NCT03065556 ·Status: COMPLETED ·Phase: PHASE2

A Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis

NCT03759197 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis

NCT02931838 ·Status: COMPLETED ·Phase: PHASE2

Paired Psoriasis Lesion, Comparative, Study to Evaluate MOL4239 in Psoriasis

NCT01826201 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Plaque Psoriasis

NCT05600036 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Efficacy and Safety of MP1032 in Patients With Chronic Plaque Psoriasis

NCT03706209 ·Status: COMPLETED ·Phase: PHASE2

Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque Psoriasis

NCT03463187 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis

NCT03482011 ·Status: COMPLETED ·Phase: PHASE3

Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies

NCT00688519 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Efalizumab in Adults With Plaque Psoriasis, Including Those Who Are Receiving Concomitant Antipsoriatic Therapies

NCT00338143 ·Status: COMPLETED ·Phase: PHASE3

A Phase 2 Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis

NCT04603027 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)

NCT03535194 ·Status: COMPLETED ·Phase: PHASE3

Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis Two of Two Phase 3 Studies

NCT00689481 ·Status: COMPLETED ·Phase: PHASE3

A Phase 2 Dose Ranging, Evaluator-Blinded Study to Evaluate the Safety of Topical IDP-118

NCT01670513 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Trial Comparing SHR-1139 Injection With Placebo in Patients With Moderate-to-severe Plaque Psoriasis

NCT06875934 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis

NCT06077331 ·Status: RECRUITING ·Phase: PHASE2

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 811 in Subjects With Psoriasis

NCT01510951 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate Safety,Tolerability,Pharmacodynamics & Pharmacokinetics of JTE-451 in Active Plaque Psoriasis Subjects

NCT03018509 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or Feet

NCT00312026 ·Status: COMPLETED ·Phase: PHASE4

A Phase 3 Study of Efficacy and Safety of AK101 in Subjects With Psoriasis

NCT05120297 ·Status: COMPLETED ·Phase: PHASE3

Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis

NCT01154101 ·Status: COMPLETED ·Phase: PHASE2

Efficacy 、Safety and PK of SHR-1314 in Patients With Moderate-to-Severe Plaque Psoriasis

NCT04839016 ·Status: UNKNOWN ·Phase: PHASE3

A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00570986 ·Status: COMPLETED ·Phase: PHASE3

An Efficacy Study of Secukinumab in Plaque Psoriasis Patients With Subclinical Psoriatic Arthritis as Measured by Musculoskeletal Ultrasound

NCT04488185 ·Status: WITHDRAWN ·Phase: PHASE4